133 related articles for article (PubMed ID: 3476378)
1. Prediction of induction and duration of complete remission in acute myelogenous leukemia: value of clonogenic cell properties.
Zittoun R; Marie JP; Brilhante D; Delmer A
Haematol Blood Transfus; 1987; 30():45-9. PubMed ID: 3476378
[No Abstract] [Full Text] [Related]
2. Contribution of clonogenic leukemic cell characteristics to therapy outcome in patients with acute myeloblastic leukemia.
Aul C; Heyll A
Haematol Blood Transfus; 1987; 30():356-60. PubMed ID: 3476367
[No Abstract] [Full Text] [Related]
3. Prognostic value of clonogenic assay for induction and duration of complete remission in acute myelogenous leukemia.
Marie JP; Zittoun R; Delmer A; Thevenin D; Suberville AM
Leukemia; 1987 Feb; 1(2):121-6. PubMed ID: 3478535
[TBL] [Abstract][Full Text] [Related]
4. Association between the secondary colony-plating efficiency of blast progenitors and the remission induction outcome of acute myeloblastic leukemia patients.
Nara N
Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1624-9. PubMed ID: 3247826
[No Abstract] [Full Text] [Related]
5. Interleukin-1 beta expression and treatment outcome in acute myelogenous leukemia.
Preisler HD; Raza A; Kukla C; Larson R; Goldberg J; Browman G
Blood; 1991 Aug; 78(3):849-50. PubMed ID: 1859896
[No Abstract] [Full Text] [Related]
6. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells.
Gustavsson A; Olofsson T
Cancer Res; 1984 Oct; 44(10):4648-52. PubMed ID: 6590116
[TBL] [Abstract][Full Text] [Related]
7. A comparison of cytokinetically based versus intensive chemotherapy for childhood acute myelogenous leukemia.
Dahl GV; Kalwinsky DK; Mirro J; Look AT
Haematol Blood Transfus; 1987; 30():83-7. PubMed ID: 3305227
[No Abstract] [Full Text] [Related]
8. Remission induction with cytarabine and daunorubicin with or without 6-thioguanine in adult patients with acute myelocytic leukemia.
Nowrousian MR; Pfeiffer R; Schaefer UW; Osieka R; Niederle N; Anders C; Schmidt CG
Haematol Blood Transfus; 1987; 30():352-5. PubMed ID: 3305206
[No Abstract] [Full Text] [Related]
9. Remission of rheumatoid arthritis with the successful treatment of acute myelogenous leukemia with cytosine arabinoside, daunorubicin, and m-AMSA.
Roubenoff R; Jones RJ; Karp JE; Stevens MB
Arthritis Rheum; 1987 Oct; 30(10):1187-90. PubMed ID: 3479115
[TBL] [Abstract][Full Text] [Related]
10. Questions regarding frontline therapy of acute myeloid leukemia.
Kantarjian H; O'Brien S
Cancer; 2010 Nov; 116(21):4896-901. PubMed ID: 20623787
[No Abstract] [Full Text] [Related]
11. Aclacinomycin-A in the induction treatment of childhood acute myelogenous leukemia.
Fink FM; Grümayer ER; Kardos G; Revesz T; Gadner H; Schuler D
Haematol Blood Transfus; 1987; 30():393-8. PubMed ID: 3305209
[No Abstract] [Full Text] [Related]
12. A phase-three trial comparing daunorubicin or idarubicin combined with cytosine arabinoside in acute myelogenous leukemia.
Vogler WR; Velez-Garcia E; Omura G; Raney M
Semin Oncol; 1989 Feb; 16(1 Suppl 2):21-4. PubMed ID: 2648581
[No Abstract] [Full Text] [Related]
13. Administration schedule of daunorubicin for elderly patients with acute myelogenous leukemia: a single-institute experience.
Dobashi N; Usui N; Yano S; Yahagi Y; Takei Y; Sugiyama K; Takahara S; Ogasawara Y; Yamaguchi Y; Saito T; Yokoyama H; Aiba K
Jpn J Clin Oncol; 2011 Jun; 41(6):820-4. PubMed ID: 21415001
[TBL] [Abstract][Full Text] [Related]
14. Etoposide in remission induction of adult acute myeloid leukemia.
Leoni F; Ciolli S; Patriarchi S; Morfini M; Rossi Ferrini P
Acta Haematol; 1990; 83(2):82-5. PubMed ID: 2106200
[TBL] [Abstract][Full Text] [Related]
15. Therapy of acute myelogenous leukemia in adults.
Petti MC; Broccia G; Caronia F; Di Raimondo F; Fioritoni G; Ladogana S; Leone G; Liso V; Musso M; Neri A
Haematol Blood Transfus; 1990; 33():249-53. PubMed ID: 2182417
[No Abstract] [Full Text] [Related]
16. Intensive sequential chemotherapy for children with acute myelogenous leukemia.
Grier HE; Gelber RD; Clavell LA; Camitta BM; Link MP; Garcea MJ; Weinstein HJ
Haematol Blood Transfus; 1990; 33():193-7. PubMed ID: 2182411
[No Abstract] [Full Text] [Related]
17. A multicentre study on intensive induction and consolidation therapy in acute myelogenous leukaemia.
Kurrle E; Ehninger G; Freund M; Heil G; Hoelzer D; Link H; Mitrou PS; Ohl S; Queisser W; Schlimok G
Blut; 1988 May; 56(5):233-6. PubMed ID: 3285914
[No Abstract] [Full Text] [Related]
18. Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes.
Krug U; Röllig C; Koschmieder A; Heinecke A; Sauerland MC; Schaich M; Thiede C; Kramer M; Braess J; Spiekermann K; Haferlach T; Haferlach C; Koschmieder S; Rohde C; Serve H; Wörmann B; Hiddemann W; Ehninger G; Berdel WE; Büchner T; Müller-Tidow C; ;
Lancet; 2010 Dec; 376(9757):2000-8. PubMed ID: 21131036
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of acute nonlymphocytic leukemia].
Preĭsler KhD; Raza A
Gematol Transfuziol; 1991 Jan; 36(1):3-8. PubMed ID: 2065944
[No Abstract] [Full Text] [Related]
20. Remission induction and maintenance modalities in acute myeloid leukemia: a multicenter randomized study.
Marty M; Lepage E; Guy H; Bordessoule D; Desablens B; Harousseau JL; Guilhot F; Leverger G; Schaison G; Boiron M
Haematol Blood Transfus; 1987; 30():50-6. PubMed ID: 3305217
[No Abstract] [Full Text] [Related]
[Next] [New Search]
